Screener
AnaptysBio, Inc. ANAB EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from AnaptysBio, Inc.’s reported figures.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
FAQ
- What is AnaptysBio, Inc.'s EBITDA?
- AnaptysBio, Inc. (ANAB) reported EBITDA of -$34.51M in Q1 2026.
- How has AnaptysBio, Inc.'s EBITDA changed year-over-year?
- AnaptysBio, Inc.'s EBITDA decreased by 26.0% year-over-year, from -$27.39M to -$34.51M.
- What is the long-term trend for AnaptysBio, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s EBITDA has grown at a -3.6% compound annual growth rate (CAGR), from -$56.2M to $48.46M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about AnaptysBio, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude